Compare Quest Diagnostics Inc (DGX) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Southern Copper Corp — how do they compare? Quest Diagnostics Inc trades at $230.97 (market cap $25.48B), while Southern Copper Corp trades at $209.21 (market cap $167.74B). The key difference: Southern Copper Corp is far larger — about 6.6× Quest Diagnostics Inc's market cap, and Southern Copper Corp pays the higher dividend (2.21%). Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Southern Copper Corp for 61 Days on average.
| DGX | SCCO | |
|---|---|---|
Market Cap | $25.48B | $167.74B |
Volume | 941,866 | 853,110 |
Sector | Health | Basic Materials |
52-Week High | $247.45 | $219.70 |
52-Week Low | $173.49 | $120.02 |
Typical Hold Time | 56 Days | 61 Days |
Enterprise Value | $31.23B | $169.03B |
Dividend Yield | 1.49% | 2.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.81, up 1.68% today, with a bullish earnings trend after beating EPS estimates for three consecutive quarters. The stock shows a mixed technical picture with a bearish overall signal but trades near key support at $228. Revenue growth accelerated to $11.04B in 2025, and the company maintains solid profitability with a 9.19% net income margin. Recent news highlights growth in consumer testing and a partnership with Apple Health, though Medicare reimbursement cuts pose a headwind.
The outlook is cautiously optimistic, supported by strong fundamentals and a consensus price target of $250 offering 8% upside. Key opportunities include demand for advanced diagnostics and AI adoption, while risks center on regulatory pressure and rising debt levels. Analyst sentiment is mixed with a slight hold bias, reflecting balanced growth prospects against near-term challenges.
Southern Copper (SCCO) trades at $198.66, down 0.95% on the day amid bearish technical signals. The stock shows strong fundamentals with revenue growth from $13.42B in 2025 to projected $15.8B in 2026 and net income margins expanding to 35.87%. Recent earnings beats and a $10.2B Mexican project pipeline support long-term growth, though valuation ratios remain elevated with P/E at 29.81.
Outlook remains mixed with strong operational performance offset by premium valuation and bearish analyst sentiment. The stock trades above consensus price target of $167.67, presenting near-term downside risk. Long-term growth drivers from copper demand and expansion projects offer potential upside, but current levels warrant caution given technical weakness and divided analyst ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
